BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16914236)

  • 1. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
    Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
    Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of monoclonal antibodies specific to P64k: a common antigen of several isolates of Neisseria meningitidis.
    Nazábal C; Carmenate T; Cruz S; González S; Silva R; Musacchio A; Delgado M; Chinea G
    Can J Microbiol; 2001 Feb; 47(2):158-64. PubMed ID: 11261496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.
    Pettersson A; Kortekaas J; Weynants VE; Voet P; Poolman JT; Bos MP; Tommassen J
    Vaccine; 2006 Apr; 24(17):3545-57. PubMed ID: 16517031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.
    Scarselli M; Cantini F; Santini L; Veggi D; Dragonetti S; Donati C; Savino S; Giuliani MM; Comanducci M; Di Marcello F; Romagnoli G; Pizza M; Banci L; Rappuoli R
    J Mol Biol; 2009 Feb; 386(1):97-108. PubMed ID: 19100746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.
    Giuliani MM; Santini L; Brunelli B; Biolchi A; Aricò B; Di Marcello F; Cartocci E; Comanducci M; Masignani V; Lozzi L; Savino S; Scarselli M; Rappuoli R; Pizza M
    Infect Immun; 2005 Feb; 73(2):1151-60. PubMed ID: 15664958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine.
    Rosenqvist E; Høiby EA; Wedege E; Caugant DA; Frøholm LO; McGuinness BT; Brooks J; Lambden PR; Heckels JE
    Microb Pathog; 1993 Sep; 15(3):197-205. PubMed ID: 7505873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immune response elicited in mice after immunization with the P64k meningococcal protein: epitope mapping.
    González S; Nazábal C; Rao KV; Reyes O; Garay HE; Caballero E; Alvarez-Obregón JC; Sardiñas G; Silva R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):233-9. PubMed ID: 15364109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes.
    Ala'Aldeen DA; Davies HA; Borriello SP
    Vaccine; 1994 May; 12(6):535-41. PubMed ID: 7518627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
    van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
    Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
    Thompson EAL; Feavers IM; Maiden MCJ
    Microbiology (Reading); 2003 Jul; 149(Pt 7):1849-1858. PubMed ID: 12855736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of P64k presensitization on its efficacy as an immunological carrier in mice.
    González S; Caballero E; Silva R; Pajón R
    Biochem Biophys Res Commun; 2001 Mar; 282(2):376-9. PubMed ID: 11401468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.
    Liang FT; Alvarez AL; Gu Y; Nowling JM; Ramamoorthy R; Philipp MT
    J Immunol; 1999 Nov; 163(10):5566-73. PubMed ID: 10553085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of a strain-specific bactericidal epitope to the surface-exposed loop 5 on the P2 porin protein of non-typeable Haemophilus influenzae.
    Yi K; Murphy TF
    Microb Pathog; 1994 Oct; 17(4):277-82. PubMed ID: 7536289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA).
    Kortekaas J; Müller SA; Ringler P; Gregorini M; Weynants VE; Rutten L; Bos MP; Tommassen J
    Microbes Infect; 2006 Jul; 8(8):2145-53. PubMed ID: 16797200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM; Smithson SL; Westerink MA
    J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.